Abstract
Stroke is one of the leading causes of mortality, and several risk factors have been identified that may be modified to ameliorate this risk. Recently, obstructive sleep apnea (OSA) has been implicated as a possible additional risk factor for stroke. OSA is a common disorder characterized by repeated upper airway collapse during sleep leading to multiple physiologic abnormalities. Several recent studies suggest that OSA is an independent risk factor for stroke. This independent association is likely due to derangement of normal sleep physiology and the attendant consequences to autonomic, vascular endothelial, and thrombotic/fibrinolytic dysfunction leading to the development of atherosclerosis. Additionally, OSAs contribution to the development of known risk factors for stroke such as hypertension and atrial fibrillation may also predispose a patient to develop cerebrovascular disease. Patients presenting with stroke who are also diagnosed with OSA have a worse prognosis than those without OSA. Therapy with continuous positive airway pressure (CPAP), the treatment of choice for most patients with OSA, appears to be beneficial, but achieving compliance in patients post-stroke is difficult.
Keywords: non-rapid eye movement phase, cerebral blood flow, patent foramen ovale, CPAP therapy, Nitric oxide
Current Respiratory Medicine Reviews
Title: Obstructive Sleep Apnea and Stroke
Volume: 3 Issue: 4
Author(s): Philip M. Alapat
Affiliation:
Keywords: non-rapid eye movement phase, cerebral blood flow, patent foramen ovale, CPAP therapy, Nitric oxide
Abstract: Stroke is one of the leading causes of mortality, and several risk factors have been identified that may be modified to ameliorate this risk. Recently, obstructive sleep apnea (OSA) has been implicated as a possible additional risk factor for stroke. OSA is a common disorder characterized by repeated upper airway collapse during sleep leading to multiple physiologic abnormalities. Several recent studies suggest that OSA is an independent risk factor for stroke. This independent association is likely due to derangement of normal sleep physiology and the attendant consequences to autonomic, vascular endothelial, and thrombotic/fibrinolytic dysfunction leading to the development of atherosclerosis. Additionally, OSAs contribution to the development of known risk factors for stroke such as hypertension and atrial fibrillation may also predispose a patient to develop cerebrovascular disease. Patients presenting with stroke who are also diagnosed with OSA have a worse prognosis than those without OSA. Therapy with continuous positive airway pressure (CPAP), the treatment of choice for most patients with OSA, appears to be beneficial, but achieving compliance in patients post-stroke is difficult.
Export Options
About this article
Cite this article as:
Alapat M. Philip, Obstructive Sleep Apnea and Stroke, Current Respiratory Medicine Reviews 2007; 3 (4) . https://dx.doi.org/10.2174/157339807782359913
DOI https://dx.doi.org/10.2174/157339807782359913 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Interleukin-6 In Rheumatoid Arthritis - From The Laboratory To The Bedside
Current Pharmaceutical Design Impaired Renal Autoregulation in Susceptible Models of Renal Disease
Current Vascular Pharmacology Mechanical Ventilation Following Cardiac Surgery in Children
Current Respiratory Medicine Reviews Vascular Disease and Insulin-Like Growth Factor-1
Vascular Disease Prevention (Discontinued) Hypercortisolemia and Glucocorticoid Receptor-Signaling Insufficiency in Alzheimer’ s Disease Initiation and Development
Current Alzheimer Research Interventions Against Sarcopenia in Older Persons
Current Pharmaceutical Design The Non-Canonical IκB Kinases IKKε and TBK1 as Potential Targets for the Development of Novel Therapeutic Drugs
Current Molecular Medicine Pharmacogenomic Approaches for Tailored Anti-Leukemic Therapy in Children
Current Medicinal Chemistry Plant Extracts and their Secondary Metabolites as Modulators of Kinases
Current Topics in Medicinal Chemistry ACE Inhibitor-Angiotensin Receptor Blocker Combinations: A Clinicians Perspective
Mini-Reviews in Medicinal Chemistry Role of the Decreased Nitric Oxide Bioavailability in the Vascular Complications of Diabetes Mellitus
Current Pharmaceutical Biotechnology Rho-Kinase and RGS-Containing RhoGEFs as Molecular Targets for the Treatment of Erectile Dysfunction
Current Pharmaceutical Design Involvement of Orexigenic Peptides in the Mechanism of Gastric Mucosal Integrity and Healing of Chronic Gastric Ulcers
Current Pharmaceutical Design Cerebrovascular Complications of Diabetes: SGLT-2 Inhibitors as a Promising Future Therapeutics
Current Drug Targets Adrenomedullin and Nitric Oxide: Implications for the Etiology and Treatment of Primary Brain Tumors
CNS & Neurological Disorders - Drug Targets L-Arginine Transport in Disease
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Virus-Associated Vasculitides: An Update
Current Immunology Reviews (Discontinued) Mediterranean Diet and Risk of Dementia
Current Alzheimer Research Mitochondrial Biogenesis: Regulation By Endogenous Gases During Inflammation and Organ Stress
Current Pharmaceutical Design Evaluating Oxidative Stress in Human Cardiovascular Disease: Methodological Aspects and Considerations
Current Medicinal Chemistry